Clinical Risks for Chronic Lymphocytic Leukemia

Area of Science:

• Hematology
• Oncology
• Cancer Genetics

Background:

• Chronic lymphocytic leukemia (CLL) risk factors are not fully understood, encompassing genetic and environmental influences.
• Despite being a familial cancer, common high-penetrance risk genes for CLL are yet to be identified.
• Previous studies identified common variants with low risks and implicated ATM in CLL development through rare variant analysis.

Purpose of the Study:

• To review and synthesize current knowledge on genetic and environmental risk factors for chronic lymphocytic leukemia (CLL).
• To discuss the role of monoclonal B-cell lymphocytosis (MBL) as a precursor and potential risk factor for CLL.
• To highlight challenges in identifying environmental exposures and their timing relative to CLL diagnosis.

Main Methods:

• Review of existing literature on CLL genetics and environmental risk factors.
• Analysis of findings from genome-wide association studies (GWAS) and exome-wide rare variant analyses.
• Discussion of epidemiological data concerning environmental exposures such as Agent Orange and glyphosate.

Main Results:

• Genome-wide association studies have identified numerous common variants associated with low CLL risk.
• Exome-wide rare variant analysis suggests a role for ATM in the causation of CLL.
• Environmental factors, including Agent Orange and glyphosate, show some supporting data but face challenges in exposure quantification and timing.

Conclusions:

• The etiology of CLL is multifactorial, involving a complex interplay of genetic predisposition and environmental exposures.
• Monoclonal B-cell lymphocytosis (MBL) is a near-universal precursor to CLL, though most MBL cases do not progress to CLL.
• Further research is needed to fully elucidate the genetic architecture and environmental triggers contributing to CLL development.